HLA-C and cancer: To address the challenges posed by MHC polymorphism and species specificity in cancer immunotherapy, humanized models, such as mice engineered to express human HLA alleles and immune components, can better recapitulate human‐specific MHC interactions and immune responses, enabling more accurate evaluation of MHC‐targeted therapies.162